Actively Recruiting

All Genders
ID06074822

Collection of Residual Neuromuscular Biopsy Samples for Research at Bordeaux University Hospital

Led by University Hospital, Bordeaux · Updated on 2023-10-10

500

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Neuromuscular diseases are rare conditions where diagnosis has improved due to advances in molecular techniques, but the exact mechanisms causing tissue damage are still not well understood. Research using animal models has helped, but studying human muscle tissue from affected patients remains essential to discover new research paths and confirm experimental findings. This project aims to support basic and translational research on these muscle diseases by collecting tissue samples. The study involves collecting leftover frozen neuromuscular biopsy samples, including nerve and muscle tissues, from patients who have undergone biopsies as part of their medical care at Bordeaux University Hospital. These samples are stored following quality standards to create a biocollection for research purposes. The project is observational and does not involve administering treatments. Participants contribute by allowing their residual biopsy samples to be preserved and stored securely for research. The collection will be maintained over 30 years to support ongoing and future studies. No additional procedures or interventions are required from participants beyond their routine care. Researchers will use these samples to better understand neuromuscular diseases and develop potential new avenues for diagnosis and treatment.

CONDITIONS

Brief Title

Research Biobank From Neuromuscular Biopsy Residues (in the Context of Care)

Who Can Participate

All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients treated at Bordeaux University Hospital in neurology, neuropediatrics, rheumatology, or medical genetics for suspected neuromuscular disease
  • Men and women of all ages, including adults and minors
Not Eligible

You will not qualify if you...

History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

Sample Collection

Duration - Ongoing throughout care

Participants provide leftover neuromuscular biopsy samples taken as part of their routine healthcare for research purposes.

Samples collected during routine healthcare visits

Long-term Monitoring

Duration - Up to 30 years

Participants' leftover biopsy samples are stored and maintained for research purposes over a long-term period.

No visits required for participants

Trial Site Locations

Total: 1 location

1

Université Hospital, Bordeaux

Bordeaux, France, 33000

Actively Recruiting

Loading map...

Research Team

M

Marie Laure NEGRIER, Pr

G

Guilhem SOLE, Dr

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Similar Trials

MAGNITUDE-2: A Phase 3, Multinational, Randomized, Double-Bl...

Neuromuscular Disease

Actively Recruiting

14 locations

A Prospective Natural History and Outcome Measure Discovery ...

Peripheral Neuropathy

Actively Recruiting

3 locations

A Proof-on-concept Study to Investigate the Potential Use of...

Neuromuscular Diseases

Actively Recruiting

2 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here